Celltrion and Celltrion Health Placement - Past Deals Have Been Mixed
Temasek aims to raise around US$450m+ via selling 1.7% of Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) each.
346 Views
Hong Kong Connect Flows: Tencent, Meituan, CNOOC, Wuxi Biologics
We highlight weekly HK Connect inflows into Tencent, Meituan, Cnooc, Wuxi Biologics, and outflows from HKEx, GWM, and Sunny Optical.
283 Views
Hong Kong Connect Flows: Wuxi Biologics, Shenhua, XPeng
We highlight weekly Hong Kong Connect inflows into Wuxi Biologics (2269 HK), Shenhua Energy (1088 HK), and Xpeng (9868 HK).
201 Views
HK Short Interest: BOC, Wuxi Biologics/Apptec
We highlight week on week short interest changes in Bank of China, Wuxi Biologics, and Wuxi Apptec based on the latest Hong Kong SFC short...
177 Views
Presentation for Webinar: China Healthcare - Outlook and Opportunities in 2022
We review the important events since 2021H1 and keep bullish on China healthcare outlook.We also analyzed investment logic and opportunities in...
259 Views